Source: The British Journal of Radiology, by Leanne Eveson; Ikboljon Sobirov; Kenneth Chan (October 1, 2026). AI-generated summary by biochip.com, published . Not independently reviewed.
Key takeaways
- Oxford researchers reviewed PCAT imaging on coronary CT as an indirect measure of vascular inflammation.
- The FAI Score adjusts CT fat measurements for technical, biological, and anatomical variation and may improve risk stratification.
- Routine clinical use remains unestablished and requires large-scale validation to show how FAI-guided care affects outcomes.
Researchers at the University of Oxford review how pericoronary adipose tissue, the fat that directly surrounds coronary arteries, could serve as an imaging-based signal of inflammation in the vessel wall. The approach uses coronary computed tomography angiography, or CCTA, a routine CT scan that visualizes coronary arteries, to measure changes in the nearby fat with the Fat Attenuation Index, or FAI. The review argues that standardized FAI scoring and artificial intelligence could make this inflammatory measure more practical for risk assessment in coronary artery disease. It is a promising direction, but routine clinical use still requires large-scale validation.
Fat Around Arteries Can Reflect What Is Happening Inside Them
Pericoronary adipose tissue, often shortened to PCAT, is not simply padding around blood vessels. It is metabolically active tissue that exchanges chemical signals with the artery wall. In healthy conditions, it can support blood-vessel function through anti-inflammatory and antioxidant effects.
When an artery becomes inflamed, however, signals including interleukin-6 and tumor necrosis factor-alpha can change the surrounding fat. The fat cells become smaller and contain less lipid, while water content rises. Think of it like a nearby material that changes its texture when exposed to heat: the fat does not directly show the inflammation, but its altered composition can provide an indirect readout of it.
How CT Detects the Signal
CCTA measures tissue density in Hounsfield units, the scale CT scanners use to distinguish materials such as air, fat, and bone. Normal PCAT is rich in lipid and has low, strongly negative attenuation values. Inflammation-associated changes make the tissue denser, shifting values toward the less negative end of the fat range.
Researchers can measure the average attenuation of fat immediately surrounding a coronary vessel, but the Fat Attenuation Index goes further. FAI assesses three-dimensional attenuation gradients around an artery, first in the proximal right coronary artery and later in the left anterior descending and left circumflex arteries. This provides a quantitative measure intended to capture local changes in perivascular fat composition.
Why Standardization Is Essential
A raw CT measurement can vary for reasons unrelated to biology. Scanner manufacturer, scan settings, patient anatomy, age, sex, and the specific coronary vessel can all influence PCAT attenuation. Those sources of variation make it difficult to compare a value from one scan or one hospital with another.
The FAI Score is designed to address that problem by correcting FAI values for technical, biological, and anatomical factors and interpreting results with age- and sex-specific nomograms. The goal is a more reproducible, platform-independent marker of coronary inflammation. Studies summarized in the review found that elevated FAI Scores predicted major adverse cardiovascular events independently of high-risk plaque features, coronary calcium scores, and clinical risk factors.
Where Artificial Intelligence Fits
Artificial intelligence can help turn a specialized image analysis into a scalable workflow. AI-based tools may automate identification of coronary arteries, segmentation of surrounding fat, and analysis of imaging features such as attenuation and texture. Radiomics, which extracts many quantitative features from medical images, may add information beyond a single average attenuation value.
That automation matters because coronary CT scans create three-dimensional datasets, and measuring PCAT consistently across vessels is technically demanding. The review presents AI as a way to improve precision and throughput, rather than as a replacement for clinical judgment or conventional measures of coronary risk.
Why This Matters
Many heart attacks arise from plaques that are not severely obstructing blood flow before they rupture or erode. Conventional CCTA can identify narrowing and several features linked to vulnerable plaque, but those visual features have limited sensitivity and positive predictive value. A marker that reflects active vascular inflammation could potentially identify risk that anatomy alone misses.
The review also highlights early evidence that treatments including statins, biologic drugs, and cardiometabolic medicines may modulate FAI Score. If serial PCAT imaging proves reliable, it could eventually help monitor whether anti-inflammatory treatment is affecting coronary inflammation. For now, the critical next step is large-scale validation showing how these measurements should guide care and whether acting on them improves patient outcomes.
Topics: Heart & vascular health · Immunity & inflammation
Start here: What is a biochip?
Related articles
- Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients’ Follow Up
- Engineering Multiscale Vasculature: Biological Principles, Design Constraints, and Advanced Biofabrication Strategies for Functional Vascular Networks
- Arthritis models for studying chikungunya virus joint inflammation
- From molecular networks to the clinic: a systems biology–nanomedicine roadmap for osteoarthritis diagnosis, regeneration, and safety-by-design